or Try an Advanced Search...

    Chemical Warfare Agents Stocks List

    Symbol Grade Name % Change
    ASTC C Astrotech Corporation -0.59
    EBS C Emergent Biosolutions, Inc. 70.98
    View As Page of Charts
    Related Industries: Aerospace & Defense Biotechnology
    Related Stock Lists: Chemical Warfare Aerospace Anthrax Anthrax Vaccines Biodefense Biological Warfare Blood Plasma Chemical Chronic Lymphocytic Leukemia Decontamination Drugs Engineering Services Explosives FDA Graft Versus Host Disease Ground Transportation Host Disease Industrial Processing Inflammatory Bowel Disease Influenza

    Related ETFs - A few ETFs which own one or more of the above listed Chemical Warfare Agents stocks.

    Symbol Grade Name Weight
    LABD D Direxion Daily S&P Biotech Bear 3X Shares 0.96
    SBB B ProShares Short SmallCap600 0.31
    SDD C ProShares UltraShort SmallCap600 0.31
    GERM C ETFMG Treatments Testing and Advancements ETF 0.29
    XHYH A BondBloxx USD High Yield Bond Healthcare Sector ETF 0.22
    View all Chemical Warfare Agents ETFs...
    Compare ETFs
    Compare LABD to SDD Compare SBB to SDD Compare SBB to XHYH

        Chemical Warfare Agents Stocks Recent News

        Date Stock Title
        May 2 EBS Q1 2024 Emergent BioSolutions Inc Earnings Call
        May 2 EBS Emergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript
        May 2 EBS Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
        May 2 EBS Emergent BioSolutions gains as results top estimates, co to cut 300 jobs
        May 2 EBS Emergent BioSolutions Inc (EBS) (Q1 2024) Earnings Call Transcript Highlights: A Strong Start ...
        May 2 EBS PRESS DIGEST- Wall Street Journal - May 2
        May 2 EBS Emergent BioSolutions (EBS) Q1 2024 Earnings Call Transcript
        May 2 EBS Emergent BioSolutions Inc. (EBS) Q1 2024 Earnings Call Transcript
        May 2 EBS Emergent BioSolutions Inc. 2024 Q1 - Results - Earnings Call Presentation
        May 1 EBS Emergent BioSolutions Reports Surprising Q1 2024 Earnings, Exceeding Revenue and Net Income ...
        May 1 EBS Narcan-Maker Emergent BioSolutions to Cut 300 Jobs, Close Facilities
        May 1 EBS Emergent Biosolutions Non-GAAP EPS of $0.59 beats by $1.45, revenue of $300.4M beats by $75.9M
        May 1 EBS Emergent BioSolutions Reports First Quarter 2024 Financial Results
        May 1 EBS Emergent BioSolutions to lay off about 300 employees
        May 1 EBS UPDATE 2-Emergent BioSolutions to lay off about 300 employees
        May 1 EBS Emergent BioSolutions announces reduction of about 300 employees
        May 1 EBS Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position
        May 1 EBS Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone
        Apr 30 EBS Emergent BioSolutions Announces Amendment to its Existing Credit Facility
        Apr 30 EBS Emergent Biosolutions Q1 2024 Earnings Preview
        Related Industries: Aerospace & Defense Biotechnology
        Related Stock Lists: Chemical Warfare Aerospace Anthrax Anthrax Vaccines Biodefense Biological Warfare Blood Plasma Chemical Chronic Lymphocytic Leukemia Decontamination Drugs Engineering Services Explosives FDA Graft Versus Host Disease Ground Transportation Host Disease Industrial Processing Inflammatory Bowel Disease Influenza
        Chemical Warfare Agents

        Chemical Warfare Agents (CWAs) are chemical substances that are used in warfare to cause death or injury to enemy combatants. These agents can be in the form of gases, liquids, or solids, and can be dispersed through the air, water, or land. Examples of CWAs include nerve agents, blister agents, and choking agents.

        Browse All Tags